Genmab A/S (GNMSF)
376.00
-20.97
(-5.28%)
USD |
OTCM |
Oct 06, 16:00
Genmab Price : 376.00 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 382.60 | 384.00 | 376.00 | 376.00 | 37320.00 |
| Oct 05, 2026 | 355.00 | 396.97 | 351.17 | 396.97 | 1656.00 |
| Oct 02, 2026 | 355.00 | 355.00 | 355.00 | 355.00 | 0.000 |
| Oct 01, 2026 | 355.00 | 355.00 | 355.00 | 355.00 | 0.000 |
| Sep 30, 2026 | 355.00 | 355.00 | 355.00 | 355.00 | 0.000 |
| Sep 29, 2026 | 355.00 | 355.00 | 355.00 | 355.00 | 0.000 |
| Sep 28, 2026 | 355.00 | 355.00 | 355.00 | 355.00 | 100.00 |
| Sep 25, 2026 | 353.00 | 353.00 | 353.00 | 353.00 | 60.00 |
| Sep 24, 2026 | 346.76 | 346.76 | 346.76 | 346.76 | 830.00 |
| Sep 23, 2026 | 338.75 | 338.75 | 338.75 | 338.75 | 1.000 |
| Sep 22, 2026 | 350.00 | 350.00 | 350.00 | 350.00 | 50.00 |
| Sep 21, 2026 | 343.00 | 343.00 | 343.00 | 343.00 | 0.000 |
| Sep 18, 2026 | 343.00 | 343.00 | 343.00 | 343.00 | 0.000 |
| Sep 17, 2026 | 343.00 | 343.00 | 343.00 | 343.00 | 209.00 |
| Sep 16, 2026 | 342.00 | 342.00 | 341.00 | 341.00 | 723.00 |
| Sep 15, 2026 | 336.25 | 338.98 | 336.25 | 338.98 | 205.00 |
| Sep 14, 2026 | 329.25 | 329.25 | 329.25 | 329.25 | 0.000 |
| Sep 11, 2026 | 329.25 | 329.25 | 329.25 | 329.25 | 0.000 |
| Sep 10, 2026 | 329.25 | 329.25 | 329.25 | 329.25 | 0.000 |
| Sep 09, 2026 | 329.25 | 329.25 | 329.25 | 329.25 | 0.000 |
| Sep 08, 2026 | 329.25 | 329.25 | 329.25 | 329.25 | 0.000 |
| Sep 04, 2026 | 329.25 | 329.25 | 329.25 | 329.25 | 6.000 |
| Sep 03, 2026 | 338.00 | 338.00 | 338.00 | 338.00 | 0.000 |
| Sep 02, 2026 | 338.00 | 338.00 | 338.00 | 338.00 | 20000.00 |
| Sep 01, 2026 | 338.00 | 338.00 | 338.00 | 338.00 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascendis Pharma A/S | 226.05 |
| Zealand Pharma A/S | 38.12 |
| Bavarian Nordic A/S | 11.10 |
| Evaxion AS | 3.16 |
| ACADIA Pharmaceuticals, Inc. | 19.74 |
Price Related Metrics
| PE Ratio | 29.70 |
| PS Ratio | 5.800 |
| Price to Book Value | 3.768 |
| Price to Free Cash Flow | 26.90 |
| Earnings Yield | 3.37% |
| Market Cap | 22.45B |
| Operating PE Ratio | 17.96 |
| Normalized PE Ratio | 24.35 |